www.dailywire.com
Morning Brief: Trump Touts Affordability, Lone Star Senate Showdown, & Vax Standards Revised
President Donald Trump highlights the administration’s affordability efforts, a key Senate race gains a new wrinkle in Texas, and mainstream science erupts at a new government memo on vaccines.
It’s Wednesday, December 10, 2025, and this is the news you need to know to start your day. Today’s edition of the Morning Wire podcast can be heard below, and the video version can be seen on The Daily Wire:
Trump Kicks Off Economy Tour
Topline: President Trump is hitting the road to tout his economic progress as Americans remain pessimistic about affordability and the cost of living.
Since retaking office, many of the president’s most high-profile road trips have been abroad to meet with foreign leaders and lock down peace deals and trade agreements. But with midterms fast approaching and affordability remaining the top issue for voters, he’s launching a nationwide tour to tout his economic record and address voter concerns on affordability.
For years now, Republicans have dominated on the topic, with poll after poll showing voters prefer their handling of the economy over Democrats. But goodwill from Trump’s first term has not carried over, as Republicans now trail Democrats on the economy.
Last month’s electoral results in New Jersey, Virginia, and New York were seemingly a wake-up call for the White House. It’s not just that Democrats won handily, but it’s the fact that they won by attacking President Trump’s economy and focusing on affordability. Now the president has held a series of meetings with his top advisers to devise a new messaging strategy to convince voters that he’s taking the right course ahead of the midterms.
Trump appeared in Pennsylvania for the first of what the White House says will be a string of events focused primarily on affordability.
Trump is in a tough political spot. On the one hand, he takes great pride in his economic prowess and his role as a sort of businessman-in-chief. But if he continues insisting that things are going great, he risks coming off as out of touch and angering folks.
A Fox News poll this month found that 76% of voters view the economy negatively, while POLITICO found that even 37% of Trump voters say the cost of living is the worst they’ve ever seen.
For his part, the president reportedly feels the issue is perception, and that Republicans must step up their efforts to highlight the progress they’re making.
“We gave you an extension of the biggest tax cuts and the biggest tax cuts ever, even bigger than the first term, and that’s one of the reasons that your 401(k)s are through the roof. It’s one of the reasons that the stock market is at the highest point,” said Trump Tuesday evening. “Rent prices are down, dairy prices are coming down very strongly. The cost of Thanksgiving turkeys was down by 33% compared to the Biden era. That’s a good start. We’re bringing it down and we’re coming down more. We’re coming down a lot more.”
President Trump also touted the progress made so far in lowering the cost of gas and eggs, which reached historic highs in recent years.
“We’re down lower than we’ve been in seven years. And gasoline prices in oil prices, not just the three states that I talk about with 1.99 a gallon,” said Trump. “ What about eggs? … The price of eggs is down now 80% since March. Think of that.”
Shootout For Texas Senate Seat
Topline: A Texas Senate race is already heating up as candidates for both parties jockey for the chance to win the key seat, and some notable names are shaking things up.
A new Democrat challenger: Rep. Jasmine Crockett (D-TX) is jumping into the race. Crockett is a sound-bite factory, so prepare to see some major developments out of the U.S. Senate race in Texas.
Former Rep. Colin Allred (D-TX) dropped out of the race earlier on Monday while signaling that Crockett was going to get in. Meanwhile, state Rep. James Talarico is maintaining that he is going to stay in the contest on the Democratic side.
Texas is a red state, but with the 2026 election, Democrats are feeling a bit cocky about their shot at winning that seat and many others, if possible.
Crockett’s impact: The NRCC, or the Republican arm focused on House elections, is already touting that Crockett could potentially be the Democratic nominee. What that means for down-ballot races is that moderate Democrats will face a choice: whether to embrace Crockett and risk being painted as radicals by Republicans, or to push away from Crockett and risk pushback from Democrats.
Either way, Republicans will likely try to paint Crockett as the standard-bearer of the Democratic Party in Texas.
GOP’s packed primary: On the Republican side, it’s a complicated primary. Incumbent Sen. John Cornyn (R-TX) is running, as well as state Attorney General Ken Paxton. Rep. Wesley Hunt (R-TX) is also in the race.
Cornyn is backed by the NRC, the official party arm that defends incumbent GOP senators. Paxton, Hunt, and Cornyn are all vying for Trump’s endorsement. But the president has not yet picked a favorite.
Hunt and Paxton have both portrayed themselves as the better option to stand with Trump and carry out the president’s agenda. But there is a highly volatile dynamic in the race, and polling shows the contest is incredibly close.
FDA Revamps Vaccine Standards
Topline: The FDA is implementing tougher standards for vaccines, a move riling up the medical establishment.
Reports circulated this week about an internal memo from Dr. Vinay Prasad, director of the FDA’s vaccine division, proposing an overhaul of how vaccines are evaluated and approved, initiating tougher standards. The new process would include full randomized clinical trials even for updated or routine vaccines, such as the flu shot.
The trials would allow evaluation of real-world protection, not just antibody levels, as well as side-effect rates and additional information for risk-benefit analysis. Currently, officials rely primarily on immune-response data, such as antibody levels from small groups of people.
Notably, this memo cited at least 10 children who died “after and because of” receiving COVID vaccines. That is apparently driving this new direction for tougher vaccine approvals.
How it’s playing: Twelve former FDA officials denounced the memo in an editorial, claiming that it casts doubt on vaccine safety. They claim these new standards reject “long-standing science” and say it will slow innovation. Former FDA head Dr. Scott Gottlieb appeared on CBS News and said Prasad’s new procedures could hamper vaccine effectiveness.
Trump admin response: The Department of Health and Human Services stands by Dr. Prasad and these new standards. An HHS spokesperson took a swipe at the “resistance” editorial, saying, “The fact these criticisms are coming from former FDA officials who opposed raising the bar for vaccine science confirms we are on the right track.”
HHS press secretary Emily Hilliard told Morning Wire that the American people “deserve evidence-based science,” and said Dr. Prasad’s email “lays out a philosophical framework that points us toward that higher standard.”
Hilliard also said HHS will “soon release documents laying out that framework,” as well as data confirming how the COVID vaccine resulted in children’s deaths that previous leadership failed to investigate properly.